This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Phosphorylation of 17β-hydroxysteroid dehydrogenase 13 at serine 33 attenuates nonalcoholic fatty liver disease in mice
Nature Communications Open Access 02 November 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Virtue, S. & Vidal-Puig, A. Nat. Metab. 3, 883–886 (2021).
Andrikopoulos, S., Blair, A. R., Deluca, N., Fam, B. C. & Proietto, J. Am. J. Physiol. Endocrinol. Metab. 295, E1323–E1332 (2008).
Ayala, J. E. et al. Dis. Model. Mech. 3, 525–534 (2010).
McGuinness, O. P., Ayala, J. E., Laughlin, M. R. & Wasserman, D. H. Am. J. Physiol. Endocrinol. Metab. 297, E849–E855 (2009).
Alquier, T. & Poitout, V. Diabetologia 61, 526–538 (2018).
Carper, D., Coué, M., Laurens, C., Langin, D. & Moro, C. Mol. Metab. 42, 101058 (2020).
Fischer, A. W., Cannon, B. & Nedergaard, J. Mol. Metab. 7, 161–170 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Moro, C., Magnan, C. GTTs and ITTs: aim for shorter fasting times. Nat Metab 3, 1133 (2021). https://doi.org/10.1038/s42255-021-00455-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s42255-021-00455-y